Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints Trial - CONVINCE

Description:

The goal of the CONVINCE trial was to determine equivalency in the incidence of MI, stroke, or cardiovascular-related death among hypertensive patients randomized to controlled onset-extended release-verapamil vs standard of care (atenolol or hydrochlorothiazide).